PON1 and coronary artery disorder: Observations that arylesterase activity provided prognostic value in both primary prevention (no evidence of CAD) and secondary prevention (evidence of CAD) subjects were interpreted as implying that a lack of antioxidant defense (due to low PON1 activity) may promote greater vulnerability to oxidative stress and to the progression of CAD.